PharmaCyte Biotech PMCB
NASDAQ PMCB
$0.35 +0.01 (+2.94%)
At close: Oct 22, 2026 · 4:00 PM EDT

PharmaCyte Biotech (PMCB) Amortization of Deferred Charges (2010 - 2012)

Updated

Analysis

PharmaCyte Biotech (PMCB) Amortization of Deferred Charges (2010 - 2012) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,140.21 Bn 1,108.80 Bn 19.71 Bn
2 Johnson & Johnson 632.33 Bn 552.19 Bn 17.30 Bn
3 AbbVie 500.02 Bn 473.13 Bn 12.70 Bn
4 Merck 355.31 Bn 309.69 Bn 12.21 Bn
5 Novartis Ag 300.67 Bn 264.66 Bn 11.24 Bn
6 Astrazeneca 263.56 Bn 237.25 Bn 12.86 Bn
7 Amgen 237.81 Bn 193.20 Bn 7.24 Bn
8 Gilead Sciences 194.42 Bn 168.61 Bn 6.22 Bn
9 Pfizer 171.28 Bn 117.93 Bn 10.94 Bn
10 PharmaCyte Biotech 4.02 Mn -68.82 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2012 -5,695.00
Apr 30, 2012 -2,701.00
Jan 31, 2012 -2,699.00
Oct 31, 2011 -2,699.00
Jul 31, 2011 -2,699.00
Apr 30, 2011 -2,701.00
Jan 31, 2011 -2,699.00
Oct 31, 2010 -2,699.00
Jul 31, 2010 -2,699.00
API Access

PharmaCyte Biotech Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=PMCB&period=max&api_key=YOUR_API_KEY